Private-equity firm Carlyle (CG) is in exclusive talks to acquire medical device maker Baxter’s kidney care spinoff Vantive for more $4B, including debt, according to The Wall Street Journal.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX: